{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:41:21Z","timestamp":1790793681646,"version":"4.1.0"},"reference-count":202,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ijpharm.2017.11.018","type":"journal-article","created":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T07:17:48Z","timestamp":1510384668000},"page":"272-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":786,"title":["Cyclodextrins: structure, physicochemical properties and pharmaceutical applications"],"prefix":"10.1016","volume":"535","author":[{"given":"Phatsawee","family":"Jansook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsteinn","family":"Loftsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.11.018_bib0005","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1248\/cpb.43.2232","article-title":"Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin","volume":"43","author":"Abe","year":"1995","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00044011-200828070-00002","article-title":"Pharmacokinetics, safety and tolerance of voriconazole in renally impaired subjects - two prospective, multicentre, open-label, parallel-group volunteer studies","volume":"28","author":"Abel","year":"2008","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0015","series-title":"Scifinder","author":"ACS","year":"2017"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/02652040400000447","article-title":"Encapsulation of insulin\u2013cyclodextrin complex in PLGA microspheres: A new approach for prolonged pulmonary insulin delivery","volume":"21","author":"Aguiar","year":"2004","journal-title":"J. Microencap."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/B:JIPH.0000011786.89533.0e","article-title":"Complex formation between purine derivatives and cyclodextrins: A fluorescence spectroscopy study","volume":"47","author":"Aicart","year":"2003","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1081\/DDC-120016730","article-title":"Influence of hydroxypropyl \u03b2-cyclodextrin on the corneal permeation of pilocarpine","volume":"29","author":"Akta\u015f","year":"2003","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0035","first-page":"559","article-title":"Cyclodextrins in acetazolamide eye drop formulations","volume":"53","author":"Ammar","year":"1998","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0040","series-title":"Questions and Answers on Cyclodextrins in the Context of the Revision of the Guideline on \u2018Excipients in the Label and Package Leaflet of Medicinal Products for Human Use\u2019 (cpmp\/463\/00 rev. 1)","first-page":"8","author":"Anonymous","year":"2014"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0045","series-title":"Background Review for Cyclodextrins Used as Excipients","first-page":"17","author":"Anonymous","year":"2014"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0050","series-title":"Proceedings of the sixth international symposium on cyclodextrins: Chicago, 21 to 24 April 1992","first-page":"277","article-title":"New aspects in cyclodextrin toxicology","author":"Antlsperger","year":"1992"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0055","series-title":"8th International Symposium on Cyclodextrins","first-page":"149","article-title":"Toxicological comparison of cyclodextrins","author":"Antlsperger","year":"1996"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0060","series-title":"Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications","first-page":"91","article-title":"Recent findings on safety profiles of cyclodextrins, cyclodextrin conjugates, and polypseudorotaxanes","author":"Arima","year":"2011"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(02)00345-9","article-title":"The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa","volume":"246","author":"Asai","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mrc.1260320103","article-title":"Investigation of the dynamics of cyclodextrins and their inclusion complexes in water by deuterium NMR","volume":"32","author":"Azaroual-Bellanger","year":"1994","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0939-6411(00)00108-9","article-title":"Considerations in the use of hydroxypropyl-\u03b2-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone","volume":"50","author":"Bary","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(97)00063-X","article-title":"Effects of physicochemical properties and other factors on systemic nasal drug delivery","volume":"29","author":"Behl","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejps.2006.10.008","article-title":"Cyclodextrin\/imatinib complexation: binding mode and charge dependent stabilities","volume":"30","author":"B\u00e9ni","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2017.04.057","article-title":"Gastrointestinal behavior of itraconazole in humans \u2013 part 2: the effect of intraluminal dilution on the performance of a cyclodextrin-based solution","volume":"526","author":"Berben","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0095","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/cbdv.200690129","article-title":"Aggregation of cyclodextrins as an important factor to determine their complexation behavior","volume":"3","author":"Bik\u00e1di","year":"2006","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcrc.2008.10.010","article-title":"Preclinical pharmacology of sugammadex","volume":"24","author":"Bom","year":"2009","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0105","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/la052878f","article-title":"Self-assembly of \u03b2-cyclodextrin in water. Part 1: cryo-TEM and dynamic and static light scattering","volume":"22","author":"Bonini","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0110","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1155\/2004\/727869","article-title":"Infrared spectroscopic study of triacetyl-\u03b2-cyclodextrin and its inclusion complex with nicardipine","volume":"18","author":"Bratu","year":"2004","journal-title":"Spectroscopy"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaccutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0120","first-page":"231","article-title":"The potential use of cyclodextrins in parenteral formulations","volume":"43","author":"Brewster","year":"1989","journal-title":"J. Parenter. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0125","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2008.02.007","article-title":"Comparative interaction of 2-hydroxypropyl-\u03b2-cyclodextrin and sulfobutylether-\u03b2-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions","volume":"34","author":"Brewster","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2007.07.018","article-title":"The utility of cyclodextrins for enhancing oral bioavailability","volume":"123","author":"Carrier","year":"2007","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijpharm.2017.11.018_bib0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1208\/pt070379","article-title":"Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl \u03b2-cyclodextrin","volume":"7","author":"Chowdary","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0140","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jpba.2008.11.002","article-title":"Influence of the preparation method on the physical\u2013chemical properties of ketoprofen\u2013cyclodextrin\u2013phosphatidylcholine ternary systems","volume":"50","author":"Cirri","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0145","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01053637","article-title":"Aggregation of cyclodextrins: an explanation of the abnormal solubility of \u03b2-cyclodextrin","volume":"13","author":"Coleman","year":"1992","journal-title":"J. Inclusion Phenom. Mol. Recognit. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0150","article-title":"Heidelberg","author":"Cramer","year":"1949","journal-title":"Die Cyclodextrine Aus St\u00e4rke. Dissertation"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0155","series-title":"Einschlussverbindungen","author":"Cramer","year":"1954"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0160","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1211\/0022357991776930","article-title":"Stability of diclofenac sodium in the inclusion complex with \u03b2-cyclodextrin in the solid state","volume":"51","author":"Cwiertnia","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF00708717","article-title":"Surface tension studies on the complexation of dodecylpyridinium chloride by \u03b2-cyclodextrin in aqueous electrolyte solutions","volume":"16","author":"Czapkiewicz","year":"1993","journal-title":"J. Inclusion Phenom. Mol. Recognit. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0170","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/rtph.1998.1219","article-title":"Disposition of 14c\u03b3-cyclodextrin in germ-free and conventional rats","volume":"27","author":"De Bie","year":"1998","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0175","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1128\/AAC.42.2.404","article-title":"Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children","volume":"42","author":"de Repentigny","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.reprotox.2015.05.010","article-title":"Juvenile animal testing of hydroxypropyl-beta-cyclodextrin in support of pediatric drug development","volume":"56","author":"De Schaepdrijver","year":"2015","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0185","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1021\/la00033a003","article-title":"A surface tension method for determining binding constants for cyclodextrin inclusion complexes of ionic surfactants","volume":"9","author":"Dharmawardana","year":"1993","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0190","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijpharm.2017.02.037","article-title":"A study of the aggregation of cyclodextrins: determination of the critical aggregation concentration, size of aggregates and thermodynamics using isodesmic and K2\u2013K models","volume":"521","author":"Do","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0195","series-title":"Cyclodextrins and Their Complexes: Chemistry, Analytical Methods, Applications","author":"Dodziuk","year":"2006"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0200","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.carbpol.2010.10.042","article-title":"Starch granule characterization by kinetic analysis of their stages during enzymic hydrolysis: 1H nuclear magnetic resonance studies","volume":"83","author":"Dona","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2005.04.007","article-title":"Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes","volume":"297","author":"Duan","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0210","series-title":"Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine Current and Future Industrial Applications","first-page":"3","article-title":"Cyclodextrins and their inclusion complexes","author":"Duch\u00eane","year":"2011"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0215","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ijpharm.2015.09.052","article-title":"Interest of cyclodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide","volume":"495","author":"Dufour","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0220","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1021\/ja00199a041","article-title":"Cyclodextrin inclusion complexes \u2013 studies of the variation in the size of alicyclic guests","volume":"111","author":"Eftink","year":"1989","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0225","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1008094702632","article-title":"Interaction of hydoxy acids with \u03b2-cyclodextrin","volume":"33","author":"Fenyvesi","year":"1999","journal-title":"J. Incl. Phenom. Macroc. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0230","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3109\/02713689309001843","article-title":"Beta-cyclodextrins enhance bioavailability of pilocarpine","volume":"12","author":"Freedman","year":"1993","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0235","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1515\/znb-1948-11-1211","article-title":"Die konstitution der schardinger-dextrine \u03b1, \u03b2 und \u03b3","volume":"3b","author":"Freudenberg","year":"1948","journal-title":"Z. Naturforsch."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0240","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/cber.19380710809","article-title":"\u00dcber die schardinger-dextrine aus st\u00e4rke","volume":"71","author":"Freudenberg","year":"1938","journal-title":"Ber. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0245","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/BF01489430","article-title":"Neue ansichten \u00fcber die st\u00e4rke","volume":"27","author":"Freudenberg","year":"1939","journal-title":"Naturwiss"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1183\/09031936.03.00018202","article-title":"A cyclosporin A\/maltosyl-alpha-cyclodextrin complex for inhalation therapy of asthma","volume":"22","author":"Fukaya","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0255","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1023065823358","article-title":"The aggregation of cyclodextrins as studied by photon correlation spectroscopy","volume":"44","author":"Gonzalez-Gaitano","year":"2002","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0260","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fct.2005.03.007","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrin (HP-\u03b2-CD): A toxicology review","volume":"43","author":"Gould","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0265","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2004.11.021","article-title":"Preparation of prostaglandin E1-hydroxypropyl-beta-cyclodextrin complex and its nasal delivery in rats","volume":"290","author":"Gu","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0270","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1128\/AAC.01540-09","article-title":"Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration","volume":"54","author":"Hafner","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0275","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/star.19930450508","article-title":"Properties and structure of aqueous solutions of hydroxypropyl-beta-cyclodextrin","volume":"45","author":"H\u00e4usler","year":"1993","journal-title":"Starch - St\u00e4rke"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0280","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(03)00389-2","article-title":"Solubilization of fluasterone in cosolvent\/cyclodextrin combinations","volume":"264","author":"He","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0285","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1021\/cr970014w","article-title":"Industrial applications of cyclodextrins","volume":"98","author":"Hedges","year":"1998","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0290","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1023\/A:1015816716544","article-title":"Nasal absorption enhancement of 17\u03b2-estradiol by dimethyl-\u03b2-cyclodextrin in rabbits and rats","volume":"7","author":"Hermens","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0295","series-title":"Advances in Analytical Chemistry and Instrumentation","first-page":"117","article-title":"Phase-solubility techniques","author":"Higuchi","year":"1965"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0300","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1021\/jp0476646","article-title":"Inorganic nanocrystal self-assembly via the inclusion interaction of \u03b2-cyclodextrins: toward 3D spherical magnetite","volume":"109","author":"Hou","year":"2005","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0305","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1023\/A:1026118813943","article-title":"Pulmonary absorption of insulin mediated by tetradecyl-beta-maltoside and dimethyl-beta-cyclodextrin","volume":"20","author":"Hussain","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1021\/js960213f","article-title":"Pharmaceutical applications of cyclodextrins. 3. Toxicological issues and safety evaluation","volume":"86","author":"Irie","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0315","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1002\/jps.21353","article-title":"Effect of dimethyl-\u03b2-cyclodextrin concentrations on the pulmonary delivery of recombinant human growth hormone dry powder in rats","volume":"97","author":"Jalalipour","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0320","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jps.21861","article-title":"Cyclodextrins as solubilizers: formation of complex aggregates","volume":"99","author":"Jansook","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0325","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijpharm.2008.07.011","article-title":"\u03b3CD\/HP\u03b3CD: Synergistic solubilization","volume":"363","author":"Jansook","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0330","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10847-010-9779-3","article-title":"Effect of self-aggregation of \u03b3-cyclodextrin on drug solubilization","volume":"68","author":"Jansook","year":"2010","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0335","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejpb.2010.07.005","article-title":"Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension","volume":"76","author":"Jansook","year":"2010","journal-title":"Eur. J. Pharm. Biopharm"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00010-5","article-title":"Ocular absorption following topical delivery","volume":"16","author":"J\u00e4rvinen","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0345","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijpharm.2015.07.040","article-title":"Development of a cyclodextrin-based aqueous cyclosporin a eye drop formulations","volume":"493","author":"J\u00f3hannsd\u00f3ttir","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0350","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijpharm.2017.07.044","article-title":"Formulations and toxicologic in vivo studies of aqueous cyclosporin a eye drops with cyclodextrin nanoparticles","volume":"529","author":"J\u00f3hannsd\u00f3ttir","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0355","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1525-1594.2003.07244.x","article-title":"The effect of cyclodextrins on the in vitro and in vivo properties of insulin-loaded poly (D,L-lactic-co-glycolic acid) microspheres","volume":"27","author":"J\u00fanior","year":"2003","journal-title":"Artif. Organs"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0360","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0378-5173(96)04660-1","article-title":"Interactions between cyclodextrins and pilocarpine - as an example of a hydrophilic drug","volume":"142","author":"Keipert","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0365","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1021\/js980109t","article-title":"Inclusion of ziprasidone mesylate with \u03b2-cyclodextrin sulfobutyl ether","volume":"87","author":"Kim","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0370","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2125.2011.04000.x","article-title":"Population pharmacokinetic-pharmacodynamic analysis for sugammadex-mediated reversal of rocuronium-induced neuromuscular blockade","volume":"72","author":"Kleijn","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0375","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1023\/A:1016081301369","article-title":"Pulmonary delivery of salmon calcitonin dry powders containing absorption enhancers in rats","volume":"13","author":"Kobayashi","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0380","first-page":"330","article-title":"Complexation of weak acids and basis with cyclodextrins: effects of substrate ionization on the estimation and interpretation of association constants","volume":"1","author":"Krishnamoorthy","year":"1996","journal-title":"Int. J. Pharm. Adv."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0385","first-page":"1199","article-title":"Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops \u2013 aqueous humor pharmacokinetics in humans","volume":"37","author":"Kristinsson","year":"1996","journal-title":"Invest. Ophthamol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0390","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2012.06.055","article-title":"Cyclodextrins","volume":"453","author":"Kurkov","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0395","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1208\/s12249-010-9482-0","article-title":"Parenteral delivery of HP\u03b2CD: effects on drug-HSA binding","volume":"11","author":"Kurkov","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0400","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10847-010-9756-x","article-title":"Drug\/cyclodextrin: beyond inclusion complexation","volume":"69","author":"Kurkov","year":"2011","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0405","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpharm.2011.04.044","article-title":"Evaluation of sugammadex self-association","volume":"413","author":"Kurkov","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0410","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.1986.2.67","article-title":"Topical ocular drug delivery: recent developments and future challenges","volume":"2","author":"Lee","year":"1986","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0415","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/jps.24331","article-title":"The effect of intravenous sulfobutylether7-\u03b2-cyclodextrin on the pharmacokinetics of a series of adamantane-containing compounds","volume":"104","author":"Leong","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0420","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1021\/js9801889","article-title":"Combined effect of complexation and pH on solubilization","volume":"87","author":"Li","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0425","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1021\/js990159d","article-title":"Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs","volume":"88","author":"Li","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0430","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the cause of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharmacol. Toxicol. Meth."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0435","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today: Technol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0440","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0445","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jpba.2005.06.022","article-title":"Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin","volume":"40","author":"Liu","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0450","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0939-6411(00)00091-6","article-title":"Modern bioavailability, bioequivalence and biopharmaceutics classification system. new scientific approaches to international regulatory standards","volume":"50","author":"Lobenberg","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0455","first-page":"733","article-title":"Increasing the cyclodextrin complexation of drugs and drug biovailability through addition of water-soluble polymers","volume":"53","author":"Loftsson","year":"1998","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0460","first-page":"363","article-title":"Drug permeation through biomembranes: cyclodextrins and the unstirred water layer","volume":"67","author":"Loftsson","year":"2012","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0465","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2015.01.022","article-title":"Excipient pharmacokinetics and profiling","volume":"480","author":"Loftsson","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0470","series-title":"Percutaneous Penetration Enhancers \u2013 Chemical Methods in Penetration Enhancement: Drug Manipulation Strategies and Vehicle Effects","first-page":"189","article-title":"Formulation of drug-cyclodextrin complexes","author":"Loftsson","year":"2015"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0475","first-page":"185","article-title":"Effects of 2-hydroxypropyl-\u03b2-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17\u03b2-estradiol","volume":"1","author":"Loftsson","year":"1989","journal-title":"Acta Pharm. Nord."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0480","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/js950534b","article-title":"Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization","volume":"85","author":"Loftsson","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0485","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.2042-7158.2010.01030.x","article-title":"Pharmaceutical applications of cyclodextrins: basic science and product development","volume":"62","author":"Loftsson","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0490","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.2042-7158.2011.01279.x","article-title":"Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes","volume":"63","author":"Loftsson","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0495","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/jps.23077","article-title":"Cyclodextrins as functional excipients: methods to enhance complexation efficiency","volume":"101","author":"Loftsson","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.044","article-title":"Cyclodextrins and their pharmaceutical applications","volume":"329","author":"Loftsson","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0505","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-5173(94)90155-4","article-title":"The effect of water-soluble polymers on drug-cyclodextrin complexation","volume":"110","author":"Loftsson","year":"1994","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0510","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.2042-7158.1994.tb03835.x","article-title":"Topically effective ocular hypertensive acetazolamide and ethoxyzolamide formulations in rabbits","volume":"46","author":"Loftsson","year":"1994","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0515","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-5173(00)00580-9","article-title":"Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray","volume":"212","author":"Loftsson","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0520","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2005.05.042","article-title":"Evaluation of cyclodextrin solubilization of drugs","volume":"302","author":"Loftsson","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0525","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10847-006-9247-2","article-title":"The complexation efficiency","volume":"57","author":"Loftsson","year":"2007","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0530","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1211\/jpp.59.5.0002","article-title":"Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops","volume":"59","author":"Loftsson","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0535","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0169-409X(98)00055-6","article-title":"Cyclodextrins in ophthalmic drug delivery","volume":"36","author":"Loftsson","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0540","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/jps.10226","article-title":"Self-association and cyclodextrin solubilization of drugs","volume":"91","author":"Loftsson","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0545","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1773-2247(04)50003-5","article-title":"The effects of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs","volume":"14","author":"Loftsson","year":"2004","journal-title":"J. Drug Del. Sci. Tech."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0550","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/jps.20047","article-title":"Self-association of cyclodextrins and cyclodextrin complexes","volume":"93","author":"Loftsson","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0555","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-5173(01)00895-X","article-title":"Cyclodextrins and drug permeability through semi-permeable cellophane membranes","volume":"232","author":"Loftsson","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0560","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/jphp.12427","article-title":"Pharmacokinetics of cyclodextrins and drugs after oral and parenteral administration of drug\/cyclodextrin complexes","volume":"68","author":"Loftsson","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0565","first-page":"25","article-title":"Preparation of solid drug\/cyclodextrin complexes of acidic and basic drugs","volume":"59","author":"Loftsson","year":"2004","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0570","first-page":"171","article-title":"Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations","volume":"63","author":"Loftsson","year":"2008","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0575","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/03639049709148496","article-title":"Effect of cyclodextrins on topical drug delivery to the eye","volume":"23","author":"Loftsson","year":"1997","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0580","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1600-0420.2002.800205.x","article-title":"Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye","volume":"80","author":"Loftsson","year":"2002","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0585","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2017.04.010","article-title":"Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye","volume":"531","author":"Loftsson","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0590","first-page":"277","article-title":"Topically effective acetazolamide eye-drop solution in man","volume":"2","author":"Loftsson","year":"1996","journal-title":"Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0595","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1208\/s12249-008-9055-7","article-title":"Carvedilol: Solubilization and cyclodextrin complexation. A technical note","volume":"9","author":"Loftsson","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0600","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijpharm.2017.01.028","article-title":"Nanoaggregation of inclusion complexes of glibenclamide with cyclodextrins","volume":"519","author":"Lucio","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0605","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"Ludwig","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0610","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.carres.2012.09.018","article-title":"In vitro investigations of \u03b1-amylase mediated hydrolysis of cyclodextrins in the presence of ibuprofen, flurbiprofen, or benzo[a]pyrene","volume":"362","author":"Lumholdt","year":"2012","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0615","article-title":"The reaction between \u03b1-amylase and captisol\u00ae and other SBE-cyclodextrins Lille, France","author":"Lumholdt","year":"2015","journal-title":"4th European Conference on Cyclodextrins"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0620","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/1061186042000223644","article-title":"Pulmonary absorption enhancement of salmon calcitonin","volume":"12","author":"Mahesh Kumar","year":"2004","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0625","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/10611869808997878","article-title":"Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs","volume":"6","author":"Marttin","year":"1998","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0630","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3109\/10717544.2014.935532","article-title":"Permeation enhancer strategies in transdermal drug delivery","volume":"23","author":"Marwah","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0635","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jps.2600841108","article-title":"Improvement of nasal bioavailability of luteinizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats","volume":"84","author":"Matsubara","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0640","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/ALN.0b013e3182065c36","article-title":"Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients","volume":"114","author":"McDonagh","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0645","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0008-6215(98)00193-1","article-title":"Non-covalent associations of cyclomaltooligosaccharides (cyclodextrins) with trans-\u03b2-carotene in water: evidence for the formation of large aggregates by light scattering and NMR spectroscopy","volume":"310","author":"Mele","year":"1998","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0650","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1023\/A:1015896405389","article-title":"Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats","volume":"8","author":"Merkus","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0655","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0169-409X(98)00054-4","article-title":"Cyclodextrins in nasal drug delivery","volume":"36","author":"Merkus","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0660","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijpharm.2009.11.035","article-title":"Self-assembled cyclodextrin aggregates and nanoparticles","volume":"387","author":"Messner","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0665","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1246\/bcsj.56.3556","article-title":"Viscosity B-coefficients, apparent molar volumes, and activity coefficients for \u03b1- and \u03b3-cyclodextrins in aqueous solutions","volume":"56","author":"Miyajima","year":"1983","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0670","series-title":"Clarke\u2019s analysis of drugs and poisons","author":"Moffat","year":"2004"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0675","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1128\/AAC.48.8.3151-3153.2004","article-title":"Pharmacokinetics of intravenous itraconazole in stable hemodialysis patients","volume":"48","author":"Mohr","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0680","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0731-7085(95)01672-4","article-title":"Analytical applications of retinoid-cyclodextrin inclusion complexes: 1. Characterization of a retinal-\u03b2-cyclodextrin complex","volume":"14","author":"Mu\u00f1oz Botella","year":"1996","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"Suppl. 1","key":"10.1016\/j.ijpharm.2017.11.018_bib0685","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yrtph.2004.05.008","article-title":"Safety assessment of \u03b3-cyclodextrin","volume":"39","author":"Munro","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0690","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpba.2015.01.058","article-title":"Analytical techniques for characterization of cyclodextrin complexes in the solid state: a review","volume":"113","author":"Mura","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0695","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-5173(98)00035-0","article-title":"Interactions of ketoprofen and ibuprofen with \u03b2-cyclodextrins in solution and in the solid state","volume":"166","author":"Mura","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0700","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0378-5173(98)00390-1","article-title":"Influence of the preparation method on the physicochemical properties of ketoprofen\u2013cyclodextrin binary systems","volume":"179","author":"Mura","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0705","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0378-5173(03)00265-5","article-title":"Ternary systems of naproxen with hydroxypropyl-\u03b2-cyclodextrin and aminoacids","volume":"260","author":"Mura","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0710","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/17512433.2.1.37","article-title":"Sugammadex: A novel selective relaxant binding agent","volume":"2","author":"Naguib","year":"2009","journal-title":"Exp. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0715","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/aos.12803","article-title":"Topical dexamethasone \u03b3-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema","volume":"93","author":"Ohira","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0720","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1023\/A:1016047215907","article-title":"The interaction of charged and uncharged drugs with neutral (HP-\u03b2-CD) and anionically charged (SBE7-\u03b2-CD) \u03b2-cyclodextrins","volume":"13","author":"Okimoto","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0725","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0928-0987(99)00002-0","article-title":"Determination of stability constant of beta-cyclodextrin complexes using the membrane permeation technique and the permeation behavior of drug-competing agent-beta-cyclodextrin ternary systems","volume":"8","author":"Ono","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0730","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jps.20525","article-title":"The binding interaction of synthetic ozonide antimalarials with natural and modified \u03b2-cyclodextrins","volume":"95","author":"Perry","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0735","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-5173(86)90201-2","article-title":"Hydroxypropyl-\u03b2-cyclodextrin: preparation and characterization; effects on solubility of drugs","volume":"29","author":"Pitha","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0740","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2015.01.025","article-title":"Solid microparticles based on chitosan or methyl-\u03b2-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate","volume":"201","author":"Rassu","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0745","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0378-5173(95)04357-8","article-title":"A study on the differentiation between amorphous piroxicam:\u03b2-cyclodextrin complex and a mixture of the two amorphous components","volume":"129","author":"Redenti","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1520-6017(200001)89:1<1::AID-JPS1>3.0.CO;2-W","article-title":"Drug\/cyclodextrin\/hydroxy acid multicomponent systems. Properties and pharmaceutical applications","volume":"89","author":"Redenti","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0755","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1248\/cpb.51.914","article-title":"Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether beta-cyclodextrin binary and ternary complexes","volume":"51","author":"Ribeiro","year":"2003","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0760","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.xphs.2016.01.019","article-title":"Self-assembly of cyclodextrins and their complexes in aqueous solutions","volume":"105","author":"Ryzhakov","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0765","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00417-005-0124-2","article-title":"Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation","volume":"244","author":"Saari","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0770","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijbiomac.2011.01.028","article-title":"Self-aggregates formation and mucoadhesive property of water-soluble \u03b2-cyclodextrin grafted with chitosan","volume":"48","author":"Sajomsang","year":"2011","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0775","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.synthmet.2009.02.045","article-title":"Supramolecular assemblies of oligothiophene derivatives bearing \u03b2-cyclodextrin","volume":"159","author":"Sakamoto","year":"2009","journal-title":"Synth. Met."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0780","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2016.03.049","article-title":"The self-assemble of natural cyclodextrins in aqueous solutions: application of miniature permeation studies for critical aggregation concentration (cac) determinations","volume":"505","author":"Saokham","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0785","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1002\/jps.24608","article-title":"A new approach for quantitative determination of \u03b3-cyclodextrin in aqueous solutions: application in aggregate determinations and solubility in hydrocortisone\/\u03b3-cyclodextrin inclusion complex","volume":"104","author":"Saokham","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0790","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijpharm.2016.10.062","article-title":"\u04af-Cyclodextrin","volume":"516","author":"Saokham","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0795","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/BF02067497","article-title":"\u00dcber thermophile bakterien aus verschiedenen speisen und milch, sowie \u00fcber einige umsetzungsprodukte derselben in kohlenhydrathaltigen n\u00e4hrl\u00f6sungen, darunter krystallisierte polysaccharide (dextrine) aus st\u00e4rke","volume":"6","author":"Schardinger","year":"1903","journal-title":"Z. Untersuch. Nahr. u. Genussm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0800","first-page":"188","article-title":"Bildung kristallisierter polysaccharide (dextrine) aus st\u00e4rkekleister durch microben","volume":"29","author":"Schardinger","year":"1911","journal-title":"Zentralbl. Bakteriol. Parasitenk. Abt. II"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0805","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1023\/A:1018999414088","article-title":"Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations","volume":"10","author":"Schipper","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0810","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF00318047","article-title":"Methylated \u03b2-cyclodextrins are able to improve the nasal absorption of salmon calcitonin","volume":"56","author":"Schipper","year":"1995","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0815","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0039-9140(94)80043-X","article-title":"Structural considerations and fluorescence spectral definition of cyclodextrin\/perylene complexes in the presence of 1-pentanol","volume":"41","author":"Schuette","year":"1994","journal-title":"Talanta"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0820","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/(SICI)1096-9888(199808)33:8<729::AID-JMS687>3.0.CO;2-U","article-title":"Study of \u03b2-cyclodextrin-ketakonazole-tartaric acid multicomponent non-covalent association by positive and netagive ionspray mass spectrometry","volume":"33","author":"Selva","year":"1998","journal-title":"J. Mass Sepectrom."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0825","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1023\/A:1015847604654","article-title":"Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations","volume":"9","author":"Shao","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0830","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1021\/js960389h","article-title":"Influence of \u03b1-cyclodextrin and hydroxyalkylated \u03b2-cyclodextrin derivatives on the in vitro corneal uptake and permeation of aqueous pilocarpine-HCl solutions","volume":"86","author":"Siefert","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0835","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1600-0420.2007.00885.x","article-title":"Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye","volume":"85","author":"Sigurdsson","year":"2007","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0840","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2004.10.004","article-title":"Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration","volume":"102","author":"Sigurdsson","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0845","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/jps.20287","article-title":"Complexation of celecoxib with \u03b2\u2010cyclodextrin: characterization of the interaction in solution and in solid state","volume":"94","author":"Sinha","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0850","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ijpharm.2016.07.063","article-title":"Displacement of itraconazole from cyclodextrin complexes in biorelevant media: in vitro evaluation of supersaturation and precipitation behavior","volume":"511","author":"Stappaerts","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0855","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/A:1023015201493","article-title":"Cyclodextrins in eye drop formulations","volume":"44","author":"Stefansson","year":"2002","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0860","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0192623307310945","volume":"36","author":"Stella","year":"2008","journal-title":"Cyclodextrins. Toxicol. Pathol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0865","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(98)00052-0","article-title":"Mechanisms of drug release from cyclodextrin complexes","volume":"36","author":"Stella","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0870","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jct.2004.10.004","article-title":"A microcalorimetric study of beta-cyclodextrin with 3-alkoxyl-2-hydroxypropyl trimethyl ammonium bromides in aqueous solutions","volume":"37","author":"Sun","year":"2005","journal-title":"J. Chem. Thermodyn."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0875","series-title":"Mins. 5th International Symposium on Cyclodextrins","first-page":"535","article-title":"Pharmacokinetic behavior and absolute bioavailability of hydroxypropyl-\u03b2-cyclodextrin after increasing doses in volunteers","author":"Szathmary","year":"1990"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0880","series-title":"Cyclodextrins and Their Industrial Uses","first-page":"173","article-title":"The metabolism, toxicity and biological effects of cyclodextrins","author":"Szejtli","year":"1987"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0885","series-title":"Cyclodextrin technology","author":"Szejtli","year":"1988"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0890","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1021\/js9704341","article-title":"Spontaneous opalescence of aqueous \u03b3-cyclodextrin solutions: complex formation or self-aggregation?","volume":"87","author":"Szente","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0895","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.1167\/iovs.11-8178","article-title":"Topical dexamethasone-cyclodextrin microparticle eye drops for diabetic macular edema","volume":"52","author":"Tanito","year":"2011","journal-title":"Invest. Ophth. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0900","doi-asserted-by":"crossref","first-page":"18583","DOI":"10.1021\/jp063684r","article-title":"Thermodynamic studies of molecular interactions in aqueous \u03b1-cyclodextrin solutions: application of McMillan\u2212Mayer and Kirkwood\u2212Buff theories","volume":"110","author":"Terdale","year":"2006","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0905","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2008.04.007","article-title":"Formulation of rifampicin\u2013cyclodextrin complexes for lung nebulization","volume":"129","author":"Tewes","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0910","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1128\/AAC.01657-08","article-title":"Inhaled voriconazole for prevention of invasive pulmonary aspergillosis","volume":"53","author":"Tolman","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0915","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1023\/A:1013034615464","article-title":"Stabilizing and solubilizing effects of sulfobutyl ether \u03b2-cyclodextrin on prostaglandin E1 analogue","volume":"18","author":"Uekama","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0920","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1021\/cr970025p","article-title":"Cyclodextrin drug carrier systems","volume":"98","author":"Uekama","year":"1998","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0925","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1023\/A:1015838215268","article-title":"Effect of 2-hydroxypropyl-\u03b2-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate","volume":"12","author":"Usayapant","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0930","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.yrtph.2004.05.011","article-title":"Disposition of 14c-\u03b1-cyclodextrin in germ-free and conventional rats","volume":"39","author":"Van Ommen","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0935","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejmech.2005.11.002","article-title":"Physico-chemical characterization of disoxaril\u2013dimethyl-\u03b2-cyclodextrin inclusion complex and in vitro permeation studies","volume":"41","author":"Ventura","year":"2006","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0940","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ejmech.2005.03.001","article-title":"Preparation of celecoxib-dimethyl-\u03b2-cyclodextrin inclusion complex: characterization and in vitro permeation study","volume":"40","author":"Ventura","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0945","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-5173(97)00317-7","article-title":"A physico-chemical study on the interaction between papaverine and natural and modified \u03b2-cyclodextrins","volume":"160","author":"Ventura","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0950","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-5173(03)00065-6","article-title":"Solubility enhancement of low soluble biologically active compounds - temperature and cosolvent dependent inclusion complexation","volume":"256","author":"Viernstein","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0955","first-page":"536","article-title":"Sur la fermentation de la f\u00e9cule par l\u2019action du ferment butyrique","volume":"112","author":"Villiers","year":"1891","journal-title":"Compt. Rend. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0960","series-title":"Physiological pharmaceutics. Barriers to drug absorption","first-page":"221","article-title":"Pulmonary drug delivery","author":"Washington","year":"2001"},{"issue":"Suppl. 2","key":"10.1016\/j.ijpharm.2017.11.018_bib0965","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00044011-200019002-00003","article-title":"An overview of host-guest chemistry and its application to nonsteroidal anti-inflammatory drugs","volume":"19","author":"Wenz","year":"2000","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0970","first-page":"12","article-title":"Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man","volume":"12","author":"Woodcock","year":"1993","journal-title":"Eur. J. Rheumatol. Inflamm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0975","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1142\/S0219581X06004267","article-title":"Cyclodextrin nanotube induced by 4, 4\u2032-bis (2-benzoxazolyl) stilbene","volume":"5","author":"Wu","year":"2006","journal-title":"Int. J. Nanosci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0980","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcis.2005.11.014","article-title":"Investigation on \u03b3-cyclodextrin nanotube induced by N,N'-diphenylbenzidine molecule","volume":"297","author":"Wu","year":"2006","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0985","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcis.2006.05.065","article-title":"Micrometer-sized rodlike structure formed by the secondary assembly of cyclodextrin nanotube","volume":"302","author":"Wu","year":"2006","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0990","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-3659(02)00367-X","article-title":"Liquid formulation of a novel non-fluorinated topical quinolone, t-3912, utilizing the synergic solubilizing effect of the combined use of magnesium ions and hydroxypropyl-\u03b2-cyclodextrin","volume":"86","author":"Yamakawa","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.11.018_bib0995","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10847-006-9243-6","article-title":"The modes of complexation of benzimidazole with aqueous \u03b2-cyclodextrin explored by phase solubility, potentiometric titration, 1h-nmr and molecular modeling studies","volume":"57","author":"Yousef","year":"2007","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib1000","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijpharm.2017.02.012","article-title":"Characterisation of aggregates of cyclodextrin-drug complexes using Taylor dispersion analysis","volume":"522","author":"Zaman","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib1005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/j.1552-4604.1998.tb04465.x","article-title":"A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection","volume":"38","author":"Zhou","year":"1998","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.11.018_bib1010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/A:1011041628797","article-title":"Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7m-\u03b2-CD to HP-\u03b2-CD","volume":"18","author":"Zia","year":"2001","journal-title":"Pharm. Res."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317310736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317310736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T13:37:49Z","timestamp":1603287469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317310736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":202,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0378517317310736"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.11.018","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclodextrins: structure, physicochemical properties and pharmaceutical applications","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}